Source: PLoS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
ABNT
BREUER, Aviva et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, v. 11, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0158779. Acesso em: 16 out. 2024.APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, 11. doi:10.1371/journal.pone.0158779NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 out. 16 ] Available from: https://doi.org/10.1371/journal.pone.0158779Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 out. 16 ] Available from: https://doi.org/10.1371/journal.pone.0158779